Literature DB >> 27073492

Establishment of a quenching probe method for detection of NPM1 mutations in acute myeloid leukemia cells.

Noriko Kawaguchi-Ihara1, Mai Itoh2, Ikuo Murohashi3, Shuji Tohda2.   

Abstract

Nucleophosmin (NPM1) mutations, generally consisting of a four base-pair insertion, are present in ~60% of all cytogenetically normal acute myeloid leukemia (AML) cases. The mutation is clinically significant as an important prognostic factor. Direct sequencing is the current standard method of mutation detection, however, it is quite costly and time consuming. The present study aimed to establish a highly sensitive quenching probe (QP) method to detect NPM1 mutations efficiently. Melting curve analysis was performed using a QP, following polymerase chain reaction for amplification of the involved region of the gene. The curve derived from the fluorescent intensity with respect to the temperature of OCI/AML3, a heterozygous NPM1 mutant AML cell line, was W-shaped with melting peaks at 61°C and 68°C. That of M-07e, the homozygous wild type cell line, was V-shaped with a melting peak at 68°C. Thus, the curve derived from the mutant allele was easily discriminated from that of the wild-type allele. The mutant allele was detected in concentrations as low as 3% as determined by a subsequent sensitivity study. With a short testing time and a high sensitivity, this assay was applicable for NPM1-mutated AML patient samples and is appropriate for screening NPM1 mutations. It does require further examination as to whether it would be useful as a detection method for other mutant alleles since NPM1 mutations may consist of 61 known types of mutant sequences. To the best of our knowledge, this is the first report describing the QP method for the detection of NPM1 mutations.

Entities:  

Keywords:  NPM1; PCR; acute myeloid leukemia; melting curve analysis; quenching probe

Year:  2016        PMID: 27073492      PMCID: PMC4812345          DOI: 10.3892/ol.2016.4225

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  Fluorescent quenching-based quantitative detection of specific DNA/RNA using a BODIPY((R)) FL-labeled probe or primer.

Authors:  S Kurata; T Kanagawa; K Yamada; M Torimura; T Yokomaku; Y Kamagata; R Kurane
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

2.  Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten disease.

Authors:  Paul G Rothberg; Denia Ramirez-Montealegre; Sharon D Frazier; David A Pearce
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

3.  Fully automated and super-rapid system for the detection of JAK2V617F mutation.

Authors:  Ruriko Tanaka; Junya Kuroda; William Stevenson; Eishi Ashihara; Takayuki Ishikawa; Tomohiko Taki; Yutaka Kobayashi; Yuri Kamitsuji; Eri Kawata; Miki Takeuchi; Yoshihide Murotani; Asumi Yokota; Mitsuharu Hirai; Satoshi Majima; Masafumi Taniwaki; Taira Maekawa; Shinya Kimura
Journal:  Leuk Res       Date:  2008-03-06       Impact factor: 3.156

Review 4.  Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.

Authors:  Rachel Rau; Patrick Brown
Journal:  Hematol Oncol       Date:  2009-12       Impact factor: 5.271

5.  Two novel NPM1 mutations in an acute myeloid leukemia patient transformed from primary myelofibrosis.

Authors:  S H Park; H-S Chi; H Shim; S Jang; C-J Park
Journal:  Int J Lab Hematol       Date:  2012-09-17       Impact factor: 2.877

6.  Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia.

Authors:  Elisabeth Oppliger Leibundgut; Naomi A Porret; Marianne Bienz Muggli; Heidi Baumgartner; Meike Dahlhaus; Gabriela M Baerlocher
Journal:  Ann Hematol       Date:  2012-11-17       Impact factor: 3.673

7.  Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia.

Authors:  N I Noguera; E Ammatuna; D Zangrilli; S Lavorgna; M Divona; F Buccisano; S Amadori; C Mecucci; B Falini; F Lo-Coco
Journal:  Leukemia       Date:  2005-08       Impact factor: 11.528

8.  Two novel NPM1 mutations in a therapy-responder AML patient.

Authors:  Annalisa Pianta; Dora Fabbro; Daniela Damiani; Mario Tiribelli; Renato Fanin; Alessandra Franzoni; Milena Romanello; Gianluca Tell; Carla Di Loreto; Giuseppe Damante
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

9.  Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.

Authors:  H Quentmeier; M P Martelli; W G Dirks; N Bolli; A Liso; R A F Macleod; I Nicoletti; R Mannucci; A Pucciarini; B Bigerna; M F Martelli; C Mecucci; H G Drexler; B Falini
Journal:  Leukemia       Date:  2005-10       Impact factor: 11.528

10.  Detection of NPM1 exon 12 mutations and FLT3 - internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia.

Authors:  Angela Y C Tan; David A Westerman; Dennis A Carney; John F Seymour; Surender Juneja; Alexander Dobrovic
Journal:  J Hematol Oncol       Date:  2008-07-29       Impact factor: 17.388

View more
  3 in total

Review 1.  Nucleophosmin in Its Interaction with Ligands.

Authors:  Ilaria Cela; Adele Di Matteo; Luca Federici
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

2.  Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia.

Authors:  G D Bailey; L Doolan; A Baskar; L C Smith; C H Seedhouse
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

3.  NPM1A in Plasma is a Potential Prognostic Biomarker in Acute Myeloid Leukemia.

Authors:  Chengming Sun; Yujie Gao; Liping Yang; Huiyuan Shao; Jie Li; Xuejun Gao; Li Ma; Mingming Lin; Jingrui Sui
Journal:  Open Life Sci       Date:  2018-08-21       Impact factor: 0.938

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.